Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Modern Trends in Pharmacopsychiatry|September 17, 2014
Inflammation, neurotoxins and psychiatric disordersAye-Mu MyintProgress in Neuro-Psychopharmacology & Biological Psychiatry|November 5, 2013
Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesisAye-Mu Myint, Yong-Ku KimJournal of Affective Disorders|August 13, 2004
Clinical application of low serum cholesterol as an indicator for suicide risk in major depressionYong-Ku Kim, Aye-Mu MyintJournal of Psychopharmacology (Oxford, England)|April 5, 2012
The metabolic syndrome in schizophrenia: is inflammation a contributing cause?Brian E Leonard, Markus Schwarz, Aye Mu MyintJournal of Neural Transmission (Vienna, Austria : 1996)|December 6, 2011
The role of the kynurenine metabolism in major depressionAye-Mu Myint, Markus J Schwarz, Norbert MüllerCurrent Pharmaceutical Design|March 3, 2011
Kynurenine pathway in schizophrenia: pathophysiological and therapeutic aspectsNorbert Müller, Aye-Mu Myint, Markus J SchwarzDialogues in Clinical Neuroscience|November 3, 2009
The impact of neuroimmune dysregulation on neuroprotection and neurotoxicity in psychiatric disorders--relation to drug treatmentNorbert Müller, Aye-Mu Myint, Markus J SchwarzNeurotoxicity Research|July 27, 2010
Inflammatory biomarkers and depressionNorbert Müller, Aye-Mu Myint, Markus J SchwarzCurrent Pharmaceutical Biotechnology|January 31, 2012
Immunological treatment options for schizophreniaNorbert Müller, Aye-Mu Myint, Markus J SchwarzAdvances in Protein Chemistry and Structural Biology|July 21, 2012
Inflammation in schizophreniaNorbert Müller, Aye-Mu Myint, Markus J SchwarzPageof 13